Medicare Enrolled
Daniel Rabb, MEDICAL DOCTOR
Optician · Gainesville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Rabb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Rabb?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Rabb
Daniel Rabb is an optician specialist in Gainesville, GA, with 20 years of NPI registration. Based on federal Medicare data, Rabb performed 4,247 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Rabb received a total of $6,540 from 34 pharmaceutical and/or device companies across 284 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Rabb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in GA
$6,540 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,247
Medicare services
Top 14% in GA for optician
Not available
Unique patients (not deduplicated)
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,629 | $4 | $21 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
566 | $53 | $275 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
463 | $36 | $206 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
283 | $473 | $2,054 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
193 | $165 | $934 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
169 | $58 | $315 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 148 | $117 | $974 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
124 | $69 | $349 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 83 | $303 | $1,252 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
66 | $92 | $750 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
63 | $464 | $1,930 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
61 | $70 | $388 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $34 | $171 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
52 | $34 | $157 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
45 | $148 | $958 |
| Intermediate wound repair, 7.6-12.5 cm This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that measures between 7.6 and 12.5 centimeters. It includes cleaning the wound and closing it with sutures to promote healing. |
43 | $234 | $1,033 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
42 | $104 | $853 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
41 | $83 | $517 |
| Surgical removal of skin cancer, 3.1-4.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue is between 3.1 and 4.0 centimeters. |
26 | $129 | $951 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
22 | $64 | $531 |
| Intermediate wound repair, face or mouth, 2.5 cm or less A medical procedure to close a wound on the face, ears, eyelids, nose, lips, or mouth that is 2.5 centimeters or smaller. This type of repair involves more than simple closure but is less complex than a major repair. |
18 | $111 | $878 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $59 | $340 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
13 | $78 | $392 |
| Complex repair of eyelid, nose, ear, or lip wound, 2.6-7.5 cm A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 2.6 and 7.5 centimeters. |
12 | $186 | $1,531 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
12 | $48 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,540
Total received (2018-2024)
Avg $934/year across 7 years
Top 20% in GA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
284
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,333
2023
$1,393
2022
$1,658
2021
$683
2020
$183
2019
$653
2018
$636
Payments by company (2024)
GENZYME CORPORATION
$493
E.R. Squibb & Sons, L.L.C.
$338
ABBVIE INC.
$150
Dermavant Sciences, Inc.
$84
Novartis Pharmaceuticals Corporation
$48
LEO Pharma Inc.
$44
Regeneron Healthcare Solutions, Inc.
$36
Janssen Biotech, Inc.
$27
MIMEDX Group, Inc.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
PFIZER INC.
$20
Incyte Corporation
$17
Lilly USA, LLC
$16
UCB, Inc.
$16
Top 3 companies account for 73.5% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$1,123
ABBVIE INC.
$1,066
PFIZER INC.
$527
Regeneron Healthcare Solutions, Inc.
$445
AbbVie, Inc.
$442
E.R. Squibb & Sons, L.L.C.
$359
Dermavant Sciences, Inc.
$325
Janssen Biotech, Inc.
$312
Ortho Dermatologics, a division of Bausch Health US, LLC
$228
AbbVie Inc.
$219
Novartis Pharmaceuticals Corporation
$203
Incyte Corporation
$202
Genentech USA, Inc.
$189
Janssen Scientific Affairs, LLC
$136
Lilly USA, LLC
$119
Amgen Inc.
$104
SUN PHARMACEUTICAL INDUSTRIES INC.
$87
Arcutis Biotherapeutics, Inc.
$71
LEO Pharma Inc.
$44
Sun Pharmaceutical Industries Inc.
$35
Helsinn Therapeutics (U.S.), Inc.
$34
MAYNE PHARMA COMMERCIAL LLC
$30
Almirall LLC
$28
Sandoz Inc.
$26
MIMEDX Group, Inc.
$25
Merck Sharp & Dohme Corporation
$23
Verrica Pharmaceuticals Inc.
$23
Organogenesis Inc.
$19
VYNE Pharmaceuticals Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
UCB, Inc.
$16
Biofrontera Inc.
$15
Aclaris Therapeutics, Inc.
$13
Mission Pharmacal Company
$13
Top 3 companies account for 41.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · AMELUZ · AMZEEQ · APEXICON E · ARAZLO · Avar · BOTOX · Bimzelx · CIBINQO · COSENTYX · DERMATITIS - DISEASE · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ESKATA · EUCRISA · Enbrel · Erivedge · HUMIRA · Humira · ILUMYA · Ilumya · JUBLIA · KERYDIN · LIBTAYO · OPZELURA · Puraply · REMICADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · Winlevi · YCANTH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
65
County median income
$77,430
Nearest hospital to ZIP centroid (approximate)
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Rabb is a clinical cardiology specialist, with above-average Medicare volume (top 14% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Rabb experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Rabb performed 1,629 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Rabb receive payments from pharmaceutical companies?
Yes. Rabb received a total of $6,540 from 34 companies across 284 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Rabb's costs compare to other opticians in Gainesville?
Rabb's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Rabb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Gainesville
Browse opticians in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Opticians in GA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in GA
Which GA opticians receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology